US Pharma MarketingBuying tissue-healing company AMS will bring H.B. Fuller into the markets for formulated biosurgicals and mechanical closures.
AMS secures shareholder support for planned sale to H.B. Fuller
AMS secures shareholder support for planned sale to H.B. Fuller is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: MedTech Dive